Iti Pharma And Healthcare Fund

Review Date: 11-04-2025

Beginning of Analysis

ITI Pharma and Healthcare Fund is the 5th ranked fund in the Sectoral/ Thematic Fund category. The category has total 20 funds. The 5 star rating shows an excellent past performance of the ITI Pharma and Healthcare Fund in Sectoral/ Thematic Fund. The fund has a Jensen Alpha of 5.89% which is higher than the category average of 1.34%. Here the fund has shown very good performance in terms of risk adjusted returns. The fund has a Sharpe Ratio of 0.65 which is higher than the category average of 0.5.
The past performance of the fund may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds. The ranking is based on proprietary methodology developed by bmsmoney. The methodology is based on the past performance of the funds and does not guarantee future performance.
Sectoral/Thematic Mutual Funds are ideal for aggressive investors seeking high returns by investing in a specific sector or theme. These funds offer targeted exposure to sectors like banking, technology, or themes like infrastructure and ESG, allowing investors to capitalize on the growth potential of these segments. However, they carry higher risks due to their concentrated exposure and are heavily dependent on the performance of the chosen sector or theme. Investors should have a long-term investment horizon, a high risk tolerance, and a good understanding of the sector or theme before investing in these funds. Additionally, timing the market and monitoring sectoral trends are crucial for success.

ITI Pharma and Healthcare Fund Return Analysis

• The fund has given a return of 2.25%, -6.14 and -9.86 in last one, three and six months respectively. In the same period the category average return was 1.71%, -4.14% and -13.5% respectively.
• ITI Pharma and Healthcare Fund has given a return of 11.93% in last one year. In the same period the Nifty 500 TRI return was 0.18%. The fund has given 11.75% more return than the benchmark return.
• The fund has given a return of 18.45% in last three years and rank 4th out of 20 funds in the category. In the same period the Nifty 500 TRI return was 11.74%. The fund has given 6.71% more return than the benchmark return.
• The fund has given a SIP return of -17.27% in last one year whereas category average SIP return is -24.98%. The fund one year return rank in the category is 2nd in 25 funds
• The fund has SIP return of 20.87% in last three years and ranks 2nd in 19 funds. Franklin India Opportunities Fund has given the highest SIP return (25.82%) in the category in last three years.

ITI Pharma and Healthcare Fund Risk Analysis

• The fund has a standard deviation of 16.4 and semi deviation of 11.81. The category average standard deviation is 15.15 and semi deviation is 10.81.
• The fund has a Value at Risk (VaR) of -24.78 and a maximum drawdown of -16.32. The category average VaR is -19.91 and the maximum drawdown is -17.78. The fund has a beta of 0.87 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.

Very Good Performance in Sectoral/ Thematic Fund Category

Good Performance in Sectoral/ Thematic Fund Category

Poor Performance in Sectoral/ Thematic Fund Category

Very Poor Performance in Sectoral/ Thematic Fund Category